Patrick Finn's Insider Trades & SAST Disclosures
Patrick Finn's most recent trade in Twist Bioscience Corp was a trade of 1,839 Common Stock done at an average price of $44.2 . Disclosure was reported to the exchange on Feb. 21, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Patrick Finn.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
Showing you 100 results sorted by most recent dates.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Twist Bioscience Corp | Patrick Finn | President and COO | Sale of securities on an exchange or to another person at price $ 44.18 per share. | 21 Feb 2025 | 1,839 | 267,724 (0%) | 0% | 44.2 | 81,242 | Common Stock |
| Twist Bioscience Corp | Patrick Finn | President and COO | Sale of securities on an exchange or to another person at price $ 49.35 per share. | 03 Feb 2025 | 2,845 | 269,199 (0%) | 0% | 49.4 | 140,406 | Common Stock |
| Twist Bioscience Corp | Patrick Finn | President and COO | Sale of securities on an exchange or to another person at price $ 50.17 per share. | 23 Jan 2025 | 2,422 | 272,044 (0%) | 0% | 50.2 | 121,501 | Common Stock |
| Twist Bioscience Corp | Patrick Finn | President and COO | Sale of securities on an exchange or to another person at price $ 45.59 per share. | 03 Jan 2025 | 229 | 274,466 (0%) | 0% | 45.6 | 10,440 | Common Stock |
| Twist Bioscience Corp | Patrick Finn | President and COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Dec 2024 | 53,634 | 274,695 (0%) | 0% | 0 | Common Stock | |
| Twist Bioscience Corp | Patrick Finn | President and COO | Sale of securities on an exchange or to another person at price $ 48.00 per share. | 11 Nov 2024 | 10,340 | 221,061 (0%) | 0% | 48.0 | 496,299 | Common Stock |
| Twist Bioscience Corp | Patrick Finn | President and COO | Sale of securities on an exchange or to another person at price $ 44.61 per share. | 06 Nov 2024 | 6,239 | 231,401 (0%) | 0% | 44.6 | 278,291 | Common Stock |
| Twist Bioscience Corp | Patrick Finn | President and COO | Sale of securities on an exchange or to another person at price $ 44.61 per share. | 06 Nov 2024 | 6,239 | 231,401 (0%) | 0% | 44.6 | 278,291 | Common Stock |
| Twist Bioscience Corp | Patrick Finn | President and COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Nov 2024 | 30,000 | 189,483 (0%) | 0% | 0 | Common Stock | |
| Twist Bioscience Corp | Patrick Finn | President and COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Nov 2024 | 27,287 | 216,770 (0%) | 0% | 0 | Common Stock | |
| Twist Bioscience Corp | Patrick Finn | President and COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Nov 2024 | 23,551 | 240,321 (0%) | 0% | 0 | Common Stock | |
| Twist Bioscience Corp | Patrick Finn | President and COO | Sale of securities on an exchange or to another person at price $ 41.56 per share. | 04 Nov 2024 | 2,681 | 237,640 (0%) | 0% | 41.6 | 111,433 | Common Stock |
| Twist Bioscience Corp | Patrick Finn | President and COO | Sale of securities on an exchange or to another person at price $ 43.09 per share. | 23 Oct 2024 | 2,261 | 159,483 (0%) | 0% | 43.1 | 97,429 | Common Stock |
| Twist Bioscience Corp | Patrick Finn | President and COO | Sale of securities on an exchange or to another person at price $ 43.21 per share. | 02 Oct 2024 | 6,865 | 161,744 (0%) | 0% | 43.2 | 296,644 | Common Stock |
| Twist Bioscience Corp | Patrick Finn | President and COO | Sale of securities on an exchange or to another person at price $ 39.93 per share. | 05 Aug 2024 | 2,885 | 168,327 (0%) | 0% | 39.9 | 115,187 | Common Stock |
| Twist Bioscience Corp | Patrick Finn | President and COO | Sale of securities on an exchange or to another person at price $ 56.62 per share. | 23 Jul 2024 | 2,207 | 171,212 (0%) | 0% | 56.6 | 124,971 | Common Stock |
| Twist Bioscience Corp | Patrick Finn | President and COO | Sale of securities on an exchange or to another person at price $ 48.00 per share. | 02 Jul 2024 | 476 | 173,419 (0%) | 0% | 48.0 | 22,849 | Common Stock |
| Twist Bioscience Corp | Patrick Finn | President and COO | Sale of securities on an exchange or to another person at price $ 37.13 per share. | 03 May 2024 | 2,311 | 173,895 (0%) | 0% | 37.1 | 85,817 | Common Stock |
| Twist Bioscience Corp | Patrick Finn | President and COO | Sale of securities on an exchange or to another person at price $ 30.12 per share. | 23 Apr 2024 | 2,174 | 176,206 (0%) | 0% | 30.1 | 65,483 | Common Stock |
| Twist Bioscience Corp | Patrick Finn | President and COO | Sale of securities on an exchange or to another person at price $ 32.74 per share. | 02 Apr 2024 | 492 | 178,380 (0%) | 0% | 32.7 | 16,106 | Common Stock |
| Twist Bioscience Corp | Finn Patrick | President and COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 36.59 per share. | 02 Feb 2024 | 2,626 | 178,140 (0%) | 0% | 36.6 | 96,085 | Common Stock |
| Twist Bioscience Corp | Patrick Finn | President and COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 34.76 per share. | 22 Jan 2024 | 2,383 | 180,766 (0%) | 0% | 34.8 | 82,833 | Common Stock |
| Twist Bioscience Corp | Finn Patrick | President and COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 36.86 per share. | 02 Jan 2024 | 382 | 183,149 (0%) | 0% | 36.9 | 14,081 | Common Stock |
| Twist Bioscience Corp | Patrick Finn | President and COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 19.46 per share. | 18 Aug 2023 | 1,028 | 92,128 (0%) | 0% | 19.5 | 20,005 | Common Stock |
| Twist Bioscience Corp | Patrick Finn | President and COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 25.09 per share. | 24 Jul 2023 | 306 | 93,007 (0%) | 0% | 25.1 | 7,678 | Common Stock |
| Twist Bioscience Corp | Patrick Finn | President and COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 25.11 per share. | 21 Jul 2023 | 2,176 | 93,313 (0%) | 0% | 25.1 | 54,639 | Common Stock |
| Twist Bioscience Corp | Patrick Finn | President and COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 20.46 per share. | 30 Jun 2023 | 457 | 95,489 (0%) | 0% | 20.5 | 9,350 | Common Stock |
| Twist Bioscience Corp | Patrick Finn | President and COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 May 2023 | 23,355 | 23,355 | - | - | Employee Stock Option (right to buy) | |
| Twist Bioscience Corp | Patrick Finn | President and COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 13.03 per share. | 19 May 2023 | 1,027 | 95,946 (0%) | 0% | 13.0 | 13,382 | Common Stock |
| Twist Bioscience Corp | Patrick Finn | President and COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 13.75 per share. | 21 Apr 2023 | 2,176 | 97,279 (0%) | 0% | 13.8 | 29,920 | Common Stock |
| Twist Bioscience Corp | Patrick Finn | President and COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 13.63 per share. | 21 Apr 2023 | 306 | 96,973 (0%) | 0% | 13.6 | 4,171 | Common Stock |
| Twist Bioscience Corp | Patrick Finn | President and COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 27.03 per share. | 30 Mar 2023 | 2,176 | 99,912 (0%) | 0% | 27.0 | 58,817 | Common Stock |
| Twist Bioscience Corp | Patrick Finn | President and COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 15.08 per share. | 30 Mar 2023 | 457 | 99,455 (0%) | 0% | 15.1 | 6,892 | Common Stock |
| Twist Bioscience Corp | Patrick Finn | President and COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 22.52 per share. | 17 Feb 2023 | 1,027 | 101,532 (0%) | 0% | 22.5 | 23,128 | Common Stock |
| Twist Bioscience Corp | Patrick Finn | President and COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Feb 2023 | 30,626 | 102,559 (0%) | 0% | 0 | Common Stock | |
| Twist Bioscience Corp | Patrick Finn | President and COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 28.74 per share. | 24 Jan 2023 | 337 | 71,933 (0%) | 0% | 28.7 | 9,685 | Common Stock |
| Twist Bioscience Corp | Patrick Finn | President and COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 23.81 per share. | 03 Jan 2023 | 283 | 72,490 (0%) | 0% | 23.8 | 6,738 | Common Stock |
| Twist Bioscience Corp | Patrick Finn | President and COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 23.81 per share. | 03 Jan 2023 | 220 | 72,270 (0%) | 0% | 23.8 | 5,238 | Common Stock |
| Twist Bioscience Corp | Patrick Finn | President and COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Dec 2022 | 35,484 | 72,773 (0%) | 0% | 0 | Common Stock | |
| Twist Bioscience Corp | Patrick Finn | President and COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 24.81 per share. | 18 Nov 2022 | 1,027 | 37,289 (0%) | 0% | 24.8 | 25,480 | Common Stock |
| Twist Bioscience Corp | Patrick Finn | President and COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 29.08 per share. | 24 Oct 2022 | 306 | 38,316 (0%) | 0% | 29.1 | 8,898 | Common Stock |
| Twist Bioscience Corp | Patrick Finn | Chief Commercial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 35.24 per share. | 30 Sep 2022 | 257 | 38,822 (0%) | 0% | 35.2 | 9,057 | Common Stock |
| Twist Bioscience Corp | Patrick Finn | Chief Commercial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 35.24 per share. | 30 Sep 2022 | 200 | 38,622 (0%) | 0% | 35.2 | 7,048 | Common Stock |
| Twist Bioscience Corp | Patrick Finn | Chief Commercial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 42.81 per share. | 19 Aug 2022 | 1,027 | 39,079 (0%) | 0% | 42.8 | 43,966 | Common Stock |
| Twist Bioscience Corp | Patrick Finn | Chief Commercial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 43.52 per share. | 22 Jul 2022 | 305 | 40,106 (0%) | 0% | 43.5 | 13,274 | Common Stock |
| Twist Bioscience Corp | Patrick Finn | Chief Commercial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 37.08 per share. | 01 Jul 2022 | 457 | 40,411 (0%) | 0% | 37.1 | 16,946 | Common Stock |
| Twist Bioscience Corp | Patrick Finn | Chief Commercial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 36.99 per share. | 20 May 2022 | 1,027 | 40,868 (0%) | 0% | 37.0 | 37,989 | Common Stock |
| Twist Bioscience Corp | Patrick Finn | Chief Commercial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 34.21 per share. | 22 Apr 2022 | 305 | 41,895 (0%) | 0% | 34.2 | 10,434 | Common Stock |
| Twist Bioscience Corp | Patrick Finn | Chief Commercial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 52.91 per share. | 01 Apr 2022 | 457 | 42,200 (0%) | 0% | 52.9 | 24,180 | Common Stock |
| Twist Bioscience Corp | Patrick Finn | Chief Commercial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 53.21 per share. | 18 Feb 2022 | 1,027 | 42,425 (0%) | 0% | 53.2 | 54,647 | Common Stock |
| Twist Bioscience Corp | Patrick Finn | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 60.52 per share. | 01 Feb 2022 | 659 | 43,452 (0%) | 0% | 60.5 | 39,883 | Common Stock |
| Twist Bioscience Corp | Patrick Finn | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Feb 2022 | 379 | 34,512 | - | - | Employee Stock Option (right to buy) | |
| Twist Bioscience Corp | Patrick Finn | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 26.66 per share. | 01 Feb 2022 | 379 | 44,111 (0%) | 0% | 26.7 | 10,104 | Common Stock |
| Twist Bioscience Corp | Patrick Finn | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 23.33 per share. | 01 Feb 2022 | 280 | 43,732 (0%) | 0% | 23.3 | 6,532 | Common Stock |
| Twist Bioscience Corp | Patrick Finn | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Feb 2022 | 280 | 19,705 | - | - | Employee Stock Option (right to buy) | |
| Twist Bioscience Corp | Patrick Finn | Chief Commercial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 55.87 per share. | 24 Jan 2022 | 336 | 43,452 (0%) | 0% | 55.9 | 18,772 | Common Stock |
| Twist Bioscience Corp | Patrick Finn | Chief Commercial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 77.39 per share. | 18 Jan 2022 | 220 | 43,788 (0%) | 0% | 77.4 | 17,026 | Common Stock |
| Twist Bioscience Corp | Patrick Finn | Chief Commercial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 77.39 per share. | 03 Jan 2022 | 283 | 44,008 (0%) | 0% | 77.4 | 21,901 | Common Stock |
| Twist Bioscience Corp | Patrick Finn | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 8.82 per share. | 29 Dec 2021 | 5,994 | 50,285 (0%) | 0% | 8.8 | 52,867 | Common Stock |
| Twist Bioscience Corp | Patrick Finn | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Dec 2021 | 5,994 | 3,279 | - | - | Employee Stock Option (right to buy) | |
| Twist Bioscience Corp | Patrick Finn | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 75.62 per share. | 29 Dec 2021 | 5,994 | 44,291 (0%) | 0% | 75.6 | 453,266 | Common Stock |
| Twist Bioscience Corp | Patrick Finn | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Dec 2021 | 6,057 | 44,291 (0%) | 0% | 0 | Common Stock | |
| Twist Bioscience Corp | Patrick Finn | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 85.09 per share. | 22 Dec 2021 | 5,994 | 38,234 (0%) | 0% | 85.1 | 510,029 | Common Stock |
| Twist Bioscience Corp | Patrick Finn | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Dec 2021 | 5,994 | 9,273 | - | - | Employee Stock Option (right to buy) | |
| Twist Bioscience Corp | Patrick Finn | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 8.82 per share. | 22 Dec 2021 | 5,994 | 44,228 (0%) | 0% | 8.8 | 52,867 | Common Stock |
| Twist Bioscience Corp | Patrick Finn | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 82.85 per share. | 21 Dec 2021 | 219 | 38,234 (0%) | 0% | 82.8 | 18,144 | Common Stock |
| Twist Bioscience Corp | Patrick Finn | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 23.33 per share. | 21 Dec 2021 | 219 | 38,453 (0%) | 0% | 23.3 | 5,109 | Common Stock |
| Twist Bioscience Corp | Patrick Finn | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Dec 2021 | 219 | 19,985 | - | - | Employee Stock Option (right to buy) | |
| Twist Bioscience Corp | Patrick Finn | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Dec 2021 | 1,517 | 34,891 | - | - | Employee Stock Option (right to buy) | |
| Twist Bioscience Corp | Patrick Finn | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 26.66 per share. | 02 Dec 2021 | 1,517 | 39,751 (0%) | 0% | 26.7 | 40,443 | Common Stock |
| Twist Bioscience Corp | Patrick Finn | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 87.06 per share. | 02 Dec 2021 | 1,172 | 38,820 (0%) | 0% | 87.1 | 102,034 | Common Stock |
| Twist Bioscience Corp | Patrick Finn | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 90.00 per share. | 02 Dec 2021 | 586 | 38,234 (0%) | 0% | 90 | 52,740 | Common Stock |
| Twist Bioscience Corp | Patrick Finn | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 23.33 per share. | 02 Dec 2021 | 241 | 39,992 (0%) | 0% | 23.3 | 5,623 | Common Stock |
| Twist Bioscience Corp | Patrick Finn | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Dec 2021 | 241 | 20,204 | - | - | Employee Stock Option (right to buy) | |
| Twist Bioscience Corp | Patrick Finn | Chief Commercial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 110.62 per share. | 19 Nov 2021 | 1,027 | 38,234 (0%) | 0% | 110.6 | 113,607 | Common Stock |
| Twist Bioscience Corp | Patrick Finn | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 127.23 per share. | 02 Nov 2021 | 1,758 | 39,261 (0%) | 0% | 127.2 | 223,670 | Common Stock |
| Twist Bioscience Corp | Patrick Finn | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 26.66 per share. | 02 Nov 2021 | 1,517 | 40,778 (0%) | 0% | 26.7 | 40,443 | Common Stock |
| Twist Bioscience Corp | Patrick Finn | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Nov 2021 | 1,517 | 36,408 | - | - | Employee Stock Option (right to buy) | |
| Twist Bioscience Corp | Patrick Finn | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Nov 2021 | 241 | 20,445 | - | - | Employee Stock Option (right to buy) | |
| Twist Bioscience Corp | Patrick Finn | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 23.33 per share. | 02 Nov 2021 | 241 | 41,019 (0%) | 0% | 23.3 | 5,623 | Common Stock |
| Twist Bioscience Corp | Patrick Finn | Chief Commercial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 117.41 per share. | 22 Oct 2021 | 305 | 39,261 (0%) | 0% | 117.4 | 35,810 | Common Stock |
| Twist Bioscience Corp | Patrick Finn | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 104.27 per share. | 04 Oct 2021 | 2,702 | 39,566 (0%) | 0% | 104.3 | 281,738 | Common Stock |
| Twist Bioscience Corp | Patrick Finn | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 26.66 per share. | 04 Oct 2021 | 1,517 | 41,441 (0%) | 0% | 26.7 | 40,443 | Common Stock |
| Twist Bioscience Corp | Patrick Finn | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Oct 2021 | 1,517 | 37,925 | - | - | Employee Stock Option (right to buy) | |
| Twist Bioscience Corp | Patrick Finn | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Oct 2021 | 827 | 20,686 | - | - | Employee Stock Option (right to buy) | |
| Twist Bioscience Corp | Patrick Finn | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 23.33 per share. | 04 Oct 2021 | 827 | 42,268 (0%) | 0% | 23.3 | 19,294 | Common Stock |
| Twist Bioscience Corp | Patrick Finn | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Oct 2021 | 358 | 15,267 | - | - | Employee Stock Option (right to buy) | |
| Twist Bioscience Corp | Patrick Finn | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 8.82 per share. | 04 Oct 2021 | 358 | 39,924 (0%) | 0% | 8.8 | 3,158 | Common Stock |
| Twist Bioscience Corp | Patrick Finn | Chief Commercial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 105.50 per share. | 04 Oct 2021 | 257 | 39,566 (0%) | 0% | 105.5 | 27,114 | Common Stock |
| Twist Bioscience Corp | Patrick Finn | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 117.99 per share. | 02 Sep 2021 | 2,702 | 39,823 (0%) | 0% | 118.0 | 318,809 | Common Stock |
| Twist Bioscience Corp | Patrick Finn | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 26.66 per share. | 02 Sep 2021 | 1,517 | 41,698 (0%) | 0% | 26.7 | 40,443 | Common Stock |
| Twist Bioscience Corp | Patrick Finn | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Sep 2021 | 1,517 | 39,442 | - | - | Employee Stock Option (right to buy) | |
| Twist Bioscience Corp | Patrick Finn | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Sep 2021 | 827 | 21,513 | - | - | Employee Stock Option (right to buy) | |
| Twist Bioscience Corp | Patrick Finn | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 23.33 per share. | 02 Sep 2021 | 827 | 42,525 (0%) | 0% | 23.3 | 19,294 | Common Stock |
| Twist Bioscience Corp | Patrick Finn | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Sep 2021 | 358 | 15,625 | - | - | Employee Stock Option (right to buy) | |
| Twist Bioscience Corp | Patrick Finn | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 8.82 per share. | 02 Sep 2021 | 358 | 40,181 (0%) | 0% | 8.8 | 3,158 | Common Stock |
| Twist Bioscience Corp | Patrick Finn | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 108.26 per share. | 24 Aug 2021 | 91 | 39,823 (0%) | 0% | 108.3 | 9,852 | Common Stock |
| Twist Bioscience Corp | Patrick Finn | Chief Commercial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 100.49 per share. | 20 Aug 2021 | 1,027 | 39,914 (0%) | 0% | 100.5 | 103,203 | Common Stock |
| Twist Bioscience Corp | Patrick Finn | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 117.27 per share. | 03 Aug 2021 | 2,702 | 40,850 (0%) | 0% | 117.3 | 316,864 | Common Stock |
| Twist Bioscience Corp | Patrick Finn | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 26.66 per share. | 03 Aug 2021 | 1,517 | 42,725 (0%) | 0% | 26.7 | 40,443 | Common Stock |
| Twist Bioscience Corp | Patrick Finn | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Aug 2021 | 1,517 | 40,959 | - | - | Employee Stock Option (right to buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges